US FDA’s Science Strategies Program Aims To Proactively Tackle Drug Development Hurdles

 
• By Sue Sutter
  
Chess game
The FDA Office of New Drugs’ Science Strategies program aims to take on some of the most challenging drug development hurdles. • Source: Shutterstock

More from Clinical Trials

More from R&D